Evidence map›Paper›PMID 23775071›Full record

ArticleThe Journal of biological chemistry2013

A novel function of Onecut1 protein as a negative regulator of MafA gene expression.

Kaoru Yamamoto, Taka-aki Matsuoka, Satoshi Kawashima, Satomi Takebe, Fumiyo Kubo, Noriyo Kubo, Takeshi Miyatsuka, Hideaki Kaneto, Iichiro Shimomura

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

  • Erratum issued
    Kubo, Noriyo [corrected to Kubo, Fumiyo]
5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Kaoru YamamotoDepartment of Metabolic Medicine, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, 565-0871 Suita, Japan.
Taka-aki Matsuoka
Satoshi Kawashima
Satomi Takebe
Fumiyo Kubo
Noriyo Kubo
Takeshi Miyatsuka
Hideaki Kaneto
Iichiro Shimomura
Osaka University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The transcription factor MafA is a key regulator of insulin gene expression and maturation of islet β cells. Despite its importance, the regulatory mechanism of MafA gene expression is still unclear. To identify the transcriptional regulators of MafA, we examined various transcription factors, which are potentially involved in β cell differentiation. An adenovirus-mediated overexpression study clearly demonstrated that Onecut1 suppresses the promoter activity of MafA through the Foxa2-binding cis-element on the MafA enhancer region (named area A). However, ChIP analysis showed that Foxa2 but not Onecut1 could directly bind to area A. Furthermore, overexpression of Onecut1 inhibited the binding of Foxa2 onto area A upon ChIP analysis. Importantly, insertion of a mutation in the Foxa2-binding site of area A significantly decreased the promoter activity of MafA. These findings suggest that Onecut1 suppresses MafA gene expression through the Foxa2-binding site. In the mouse pancreas, MafA expression was first detected at the latest stage of β cell differentiation and was scarcely observed in Onecut1-positive cells during pancreas development. In addition, Onecut1 expression was significantly increased in the islets of diabetic db/db mice, whereas MafA expression was markedly decreased. The improved glucose levels of db/db mice with insulin injections significantly reduced Onecut1 expression and rescued the reduction of MafA expression. These in vivo experiments also suggest that Onecut1 is a negative regulator of MafA gene expression. This study implicates the novel role of Onecut1 in the control of normal β cell differentiation and its involvement in β cell dysfunction under diabetic conditions by suppressing MafA gene expression.

Indexed as

Gene ExpressionAnimalsBinding SitesBlotting, WesternCell DifferentiationCell Line, TumorDiabetes Mellitus, Type 2Enhancer Elements, GeneticGene Expression Regulation, DevelopmentalHepatocyte Nuclear Factor 3-betaHepatocyte Nuclear Factor 6ImmunohistochemistryInsulin-Secreting CellsMaf Transcription Factors, LargeMiceMice, Inbred C57BLFoxa2 protein, mouseHepatocyte Nuclear Factor 3-betaHepatocyte Nuclear Factor 6Mafa protein, mouseMaf Transcription Factors, LargeOnecut1 protein, mouseCell BiologyDiabetesInsulin SynthesisIsletTranscription Factors

Identifiers

PMID23775071
PMCPMC3724624
OpenAlexW2075487997

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.